Light Sciences Adipose to Present at Medtech Insight and Windhover Information's "In3 East" Conference, October 18-20, 2006 in Boston, Massachusetts.BOSTON & SNOQUALMIE, Wash. -- Light Sciences Adipose adipose /ad·i·pose/ (ad´i-pos) 1. fatty. 2. the fat present in the cells of adipose tissue. ad·i·pose adj. Of, relating to, or composed of animal fat; fatty. has announced that it will present at the Medtech Insight and Windhover Information's "In3 East" Investor Conference, being held October 18-20, 2006, at The Westin Hotel Copley Place, Boston, Massachusetts. Light Sciences Adipose is developing a combination drug/device therapeutic system to safely reduce visceral fat with minimally invasive methods. Research suggests that when visceral fat is removed or reduced, insulin resistance may be improved or reversed. During treatment with the Light Sciences Adipose system, the patient is given an intravenous injection of a photosensitizing photosensitizing causing photosensitivity. photosensitizing plants some plants carry primary photodynamic agents, e.g. Hypericum perforatum. drug followed by placement of a small light-emitting device that is about one millimeter in diameter. The light device is placed under CT or laparoscopic Laparoscopic A minimally-invasive surgical or diagnostic procedure that uses a flexible endoscope (laparoscope) to view and operate on structures in the abdomen. Mentioned in: Obstetrical Emergencies guidance into the tissues to be reduced. The device has tiny light-emitting diodes that are activated for approximately one hour, after which the catheter is removed. The adipose cells should gradually break down and be reabsorbed, leading to a reduced volume of visceral fat with a subsequent decrease of insulin resistance. Reversal of insulin resistance using the Light Sciences Adipose system may ultimately help prevent more serious and costly complications of diabetes, such as cardiovascular disease, renal failure, peripheral vascular disease Peripheral Vascular Disease Definition Peripheral vascular disease is a narrowing of blood vessels that restricts blood flow. It mostly occurs in the legs, but is sometimes seen in the arms. , and diabetic retinopathy. Light Sciences Adipose is also developing a similar aesthetic system which would be used to selectively reduce subcutaneous fat deposits. The Light Sciences Adipose system would offer a minimally invasive, and ultimately a noninvasive treatment to augment or replace liposuction. About Light Sciences Adipose Light Sciences Adipose is a wholly owned subsidiary Wholly Owned Subsidiary A subsidiary whose parent company owns 100% of its common stock. Notes: In other words, the parent company owns the company outright and there are no minority owners. of Light Sciences LLC (Logical Link Control) See "LANs" under data link protocol. LLC - Logical Link Control , a privately-owned company located in Snoqualmie, WA, outside of Seattle. Light Sciences was founded in 1995 as a limited partnership and incorporated in August 2000. By 2004, development of the technology had progressed to a stage that enabled Light Sciences LLC to create specialized subsidiaries to focus further development of the system on distinct business opportunities. Light Sciences Oncology received venture funding in October 2005 and was spun-off as an independent company. Following this, Light Sciences LLC created Light Sciences Adipose to develop the technology in the area of bariatric Bariatric Pertaining to the study, prevention, or treatment of overweight. Mentioned in: Malnutrition medicine and endocrinology. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion